PHASE FORWARD INC
			Symbol			PFWD

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm™ Electronic Data Capture Solution

2009-11-05 03:00 ET - News Release

Specialist in Early Development Services Will Use InForm Product and Central Designer Module to Streamline Clinical Trial Delivery

Company Website: http://www.phaseforward.com
WALTHAM, Mass. -- (Business Wire)

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad range of pharmaceutical and biotech customers.

Quotient Clinical, a strategic business unit of Quotient Bioresearch (“Quotient”), is implementing Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution to support data collection, management and analysis for its clinical trials. In addition, the company will use Phase Forward’s Central Designer™ module to enhance eCRF design efficiency and improve workflow in the study development process for EDC trials.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.